Executive Summary
NASA dominates with $7.0B+ in long-term space propulsion/R&D contracts to Northrop Grumman ($4.4B), Boeing ($1.2B), L3Harris ($1.0B), and Lockheed Martin ($295M total), signaling bullish stability for aerospace primes through 2027-2048 amid SLS/GEOXO/DAVINCI programs. Steady multi-year revenue in IT/services ($3.5B+ across Accenture, CACI, Booz Allen) and health/construction ($1.5B+) underscores resilient federal spending in education, VA, HHS, and DOL. 22/28 bullish signals highlight unexercised options (~$5B+ potential) and extensions as key upside, though long durations and subaward dependencies warrant monitoring.
Tracking the trend? Catch up on the prior New Federal Contractors digest from January 15, 2026.
Investment Signals(4)
- NASA Space R&D Boom(HIGH)▲
Top 4 contracts total $6.9B for propulsion/spacecraft to Northrop, Boeing, L3Harris, Lockheed, with performance to 2048 and $784M-$958M outlayed.
- IT/Services Revenue Lock-in(HIGH)▲
$3.2B+ in competed awards to Accenture ($1.5B+), CACI ($960M), Booz Allen ($860M) for education, intel, VA EHRM through 2025-2027.
- Health/Construction Commitments(MEDIUM)▲
$1.3B+ for HHS/VA/DOI projects including $755M NIH building, $446M CMS MAC, $46M VA EHRM upgrades through 2029.
- Subaward Heaviness(HIGH)▲
High subawards in 15+ contracts (e.g., Booz Allen 97%, General Dynamics $294M > obligation) risk execution dependencies.
Risk Flags(4)
- Execution[HIGH RISK]▼
Long performance periods (10+ years in 6 contracts to 2039/2048) expose to funding shifts/delays; low outlays in new awards (e.g., $0 in 7 contracts).
- Execution[MEDIUM RISK]▼
Firm fixed price in 12 contracts risks cost overruns (e.g., Hensel Phelps $755M, Manhattan Telecom $132M).
- Market[MEDIUM RISK]▼
Award fee structures in 8 cost-plus contracts tie payments to performance amid potential budget scrutiny.
- Competitive[LOW RISK]▼
Small business set-asides (9 contracts) limit primes but favor niche players; recertification risks for SDVOSB/8(a).
Opportunities(3)
- ◆
Unexercised options total ~$5B+ (e.g., Lockheed GEOXO $2B potential, CACI $1.5B+, ECS $429M).
- ◆
Extensions in 15+ contracts (e.g., Booz Allen to 2027, Accenture Interior to 2031) signal follow-ons in IT/space/health.
- ◆
Small/mid-cap wins (e.g., Defense Unicorns $53M SBIR, Serrato $43M Job Corps) in set-asides for scaling.
Sector Themes(3)
- ◆
53% of value ($6.9B/13B) in long-duration propulsion/R&D contracts to majors, with 20-35yr spans.
- ◆
25% value in multi-year IT (Title IV, EHRM, immigration) and health admin/construction.
- ◆
9/28 awards to small/SDVOSB/8(a) firms totaling $400M+ in IT/construction/training.
Watch List(4)
- 👁
{"entity"=>"Northrop Grumman", "reason"=>"$4.4B NASA propulsion through 2026 with $958M outlayed; largest single award.", "trigger"=>"Ares I-X test milestones or FY2027 funding"}
- 👁
{"entity"=>"Lockheed Martin", "reason"=>"$295M NASA (GEOXO/DAVINCI) with $2B+ options to 2048.", "trigger"=>"Option exercises >$263M obligation"}
- 👁
{"entity"=>"Accenture Federal Services", "reason"=>"$1.56B across Ed/Interior; high subawards but steady outlays.", "trigger"=>"2025 Education contract renewal"}
- 👁
{"entity"=>"Small business cohort (Dawes, EKAGRA, Serrato)", "reason"=>"$130M+ wins in VA/DHS/DOL set-asides with strong outlay progress.", "trigger"=>"Follow-on set-aside awards"}
Get daily alerts with 4 investment signals, 4 risk alerts, 3 opportunities and full AI analysis of all 28 filings
🇺🇸 More from United States
View all →March 25, 2026
US Pre-Market SEC Filings Roundup — March 25, 2026
US Pre-Market SEC Filings Roundup
March 24, 2026
US Merger & Acquisition SEC Filings — March 24, 2026
US Merger & Acquisition SEC Filings
March 24, 2026
US Corporate Board Director Changes SEC Filings — March 24, 2026
US Corporate Board Director Changes SEC Filings
March 24, 2026
US Executive Officer Management Changes SEC — March 24, 2026
US Executive Officer Management Changes SEC